Benzinga | Nov 2, 2021 10:18AM EDT

Apollo Endosurgery Q3 EPS $(0.23) Beats $(0.28) Estimate, Sales $16.40M Beat $15.47M Estimate

Apollo Endosurgery (NASDAQ:APEN) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.28) by 17.86 percent. This is a 109.09 percent decrease over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $16.40 million which beat the analyst consensus estimate of $15.47 million by 6.01 percent. This is a 27.87 percent increase over sales of $12.83 million the same period last year.